Regenerative medicine is one of the fastest-growing cash-pay categories in medicine, and more practice owners are looking at adipose-derived (fat-sourced) stem cell services as a way to enter it. The equipment decision is where most of them get stuck — the market is a mix of standalone harvesting kits, surgical systems built for the OR, and platforms that bundle harvesting into something broader. Here’s a practical framework for evaluating any of them, written for the person signing the lease, not the person writing the clinical paper.
1. Is it staff-operated or does it need a specialist?
This is the question that determines whether the service line is viable for your practice or just aspirational. A harvesting approach that requires a fellowship-trained surgeon is a hiring problem before it’s a revenue opportunity. Look for a system designed to be staff-operated — where a trained member of your existing team performs the harvest under your practice’s physician supervision, rather than one that assumes you’ll recruit a specialist. The FunSculpting® Smart Harvest platform is built this way: the same staff-operated system practices already run for body contouring performs the harvest, so the operator you certify for one line covers the other.
2. What does the harvest actually require of the patient?
Ask how invasive the harvest is, and press for specifics. A harvest that demands general anesthesia and an OR is a different business — and a different risk profile — than one performed awake in a treatment room. The Smart Harvest procedure is done under local anesthesia, takes roughly fifteen minutes, and collects about 50cc of adipose tissue in a standard treatment room. That matters for two reasons: it keeps the procedure inside the scope of a properly supervised in-office team, and it’s an experience a cash-pay patient will actually book.
3. Where does processing happen, and can the material be banked?
Harvesting is only half the workflow. The tissue has to be processed, and how that’s handled shapes both your economics and your patient relationship. Understand who processes the material, and — critically — whether a patient’s harvested cells can be stored and re-retrieved later without repeating the harvest. A model where one harvest supports future infusions is fundamentally more patient-friendly, and more of a recurring relationship, than one that requires a new procedure every time.
4. One platform or a single-purpose machine?
A standalone harvesting device has to justify its entire cost against one service line and one stream of patients. That’s a harder business case than most practice owners realize going in. The alternative worth weighing is a platform that already earns its keep on a second service line. Because Smart Harvest runs on the same FDA 510(k)-cleared, no-per-use-fee platform practices use for body contouring — in a standard 8×8 room — the regenerative capability is added on infrastructure that’s already paid for, and the two lines share the same trained staff and overlapping cash-pay patients.
5. What does the training and support actually cover?
The most common way a device purchase fails is the same in regenerative medicine as in body contouring: the equipment ships and the practice is left to figure out the protocols alone. Ask exactly what’s included. The FunSculpting® model bundles 40 hours of didactic training plus hands-on certification, proctoring of your first cases in your own clinic, and stem cell and fat transfer protocols in the same program — so the harvest workflow is taught, not just the machine. Business development coaching and 90 days of launch marketing with guaranteed leads are part of the same package.
6. Are you clear on the regulatory frame?
Straight talk matters most here. Autologous regenerative services of this kind are not FDA-approved for the treatment of any specific medical condition, and they’re properly positioned as supporting general health and wellness — not as a cure for anything. State scope-of-practice and physician-oversight requirements vary, and a responsible platform partner should be able to walk you through how the service is framed and supervised for your state and specialty. If a vendor is making disease-cure promises, treat that as a red flag about the vendor, not a selling point.
The shortcut
Most of these questions collapse into one: is the harvesting device a single-purpose machine you have to build an entire practice around, or a capability that extends a platform your staff already runs? For a practice already doing — or considering — body contouring, the second path is dramatically lower-risk, because the equipment, the room, the trained operator, and the patient base are shared.
The honest way to evaluate it is against your own practice: your space, your staff, your specialty, and your local market. That’s what the Practice Growth Call is for — 30 minutes on the harvest workflow, the training path, the compliance questions for your state, and the economics against your patient base.
